86944929
Mar 18, 2016
ALNYLAM PHARMACEUTICALS INC.
Subscribe
Pharmaceutical preparations for the treatment of transthyretin-mediated amyloidosis; Pharmaceutical preparations for the treatment of familial amyloidotic polyneuropathy